Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
In plain words A study of burdock Root in people 35 to 65, run by OMNIFARMA LLC. It plans to enroll about 100 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 35 to 65. Conditions: Hyperuricemia or Gout.
- Hyperuricaemia confirmed by a laboratory, uric acid level from 360 to 540 μmol/L in women and from 420 to 540 μmol/L in men;
- Age from 35 to 65 years at the baseline;
- Patients examined by an experienced specialist not revealing any clinical evidences of gout or other somatic consequences of hyperuricaemia;
- Not taking any other nutritional additives;
4 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Burdock ( Arctium lappa L.) root extract in a form of a nutritional additive; Placebo
Registered summary
Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo
Where, as registered
No US site; Ukraine (1).